Vial

FEBRUARY 15, 2024

Pharmaceutical companies often face challenges in conducting clinical trials due to the need for substantial knowledge, time, and resources. To address these challenges, many companies outsource their clinical trials to contract research organizations (CROs) with established protocols, global reach, and therapeutic area expertise1.

Pharma Companies 52

Pharma Companies Clinical Trials Compliance Trials 52

DrugBaron

OCTOBER 17, 2022

Over the next few years, the practice of asset-centric investing was honed through various iterations all designed to counter the inherent progression bias that damages returns in pharmaceutical R&D. Doing that allowed the creation of new tools that are appropriate to deploy much later in the pharmaceutical R&D process.

Pharma Companies 100

Pharma Companies Pharmaceuticals Drug Development Production 100

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. I am a pharmacist by training and continued with a PhD in Clinical Pharmacology.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

The Connected Lab

APRIL 8, 2020

Prescription drugs have the ability to transform a patient’s life and provides them the opportunity to rid a devastating illness, making the development and approval of these medications urgent and necessary. However, over the last 10 years the path leading to drug approval has become more complicated and expensive.

Pharma Companies 52

Pharma Companies Laboratories Drugs FDA Approval 52

Drug Patent Watch

JANUARY 9, 2025

Navigating the complex landscape of drug development and manufacturing can be a daunting task. The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation. Ensuring Data Integrity Data integrity is paramount in pharmaceutical manufacturing.

Compliance 52

Compliance Drug Development Therapies Pharma Companies 52

Drug Target Review

APRIL 19, 2024

Sibylla’s scientific founders come from very different scientific fields that do not usually speak to each other, such as theoretical physics, molecular biology and pharmaceutical chemistry. Identifying new drugs is an extremely complex project. We are now in the preclinical stage of developing a proprietary drug pipeline.

Molecular Biology 111

Molecular Biology Research Pharmaceuticals Small Molecule 111

The Pharma Data

SEPTEMBER 22, 2020

Swiss pharma company to acquire biotech for $449m (€380m). Swiss pharma company Roche is set to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m). Activated NLRP3 is involved in the production of pro-inflammatory cytokines IL-1? Source link.

Pharma Companies 52

Pharma Companies Small Molecule Pharmaceutical Companies Disease 52

H1 Blog

JULY 30, 2024

This effort seeks to provide the pharmaceutical industry with more accurate representation of patient populations, thereby enhancing the safety and efficacy for prescription drugs and medical devices. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements. “Now,

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

Drug Target Review

MARCH 15, 2024

Cultural differences between the UK and mainland Europe were still quite different then but we settled in Southampton and I later went to University in Brighton, studied for a D.Phil, and found a job at a Pharma company. How important is it to have role models for young women working in the pharmaceutical industry?

Organic Chemistry 59

Organic Chemistry Pharma Companies Clinical Trials Pharmaceuticals 59

Alta Sciences

MARCH 27, 2024

Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy nbartlett Wed, 03/27/2024 - 20:21 Here at Altasciences, Eryn is responsible for guiding regulatory strategies , conducting gap analyses, and leading interactions with regulatory agencies dur ing early drug development.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

The Pharma Data

NOVEMBER 20, 2020

According to a benchmarking survey by TraceLink , 532 global supply chain leaders from various leading pharma companies, wholesale distributors, hospitals and pharmacies have indicated the supply chain has been severely impacted by the Covid-19 pandemic. Save your early bird seat now.

Pharma Companies 52

Pharma Companies Vaccine Drugs Pharmacy 52

PPD

JULY 13, 2023

At the beginning of 2023, the PPD clinical research business of Thermo Fisher Scientific surveyed 120 drug developers across the pharmaceutical, biopharmaceutical and biotechnology sectors (referred to collectively as “pharma”) to learn more about sponsors’ current needs for site and patient recruitment services.

Clinical Trials 52

Clinical Trials Pharma Companies Trials Clinical Research 52

Elrig

APRIL 29, 2024

Webinar | Ai At The Frontier: Empowering Early Career Professionals In Drug Discovery WEBINAR – ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? Are you curious about the cutting-edge intersection of Artificial Intelligence and Drug Discovery?

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Drug Target Review

JANUARY 19, 2024

I worked on a project that required development of a highly sensitive method and analysis of an active pharmaceutical ingredient to determine accurate levels of two potential genotoxic impurities. We are responsible for formulating a long-term strategy for addressing nitrosamine impurities in pharmaceuticals.

Synthetic Chemistry 105

Synthetic Chemistry Analytical Chemistry Pharmaceuticals Pharma Companies 105

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

Eye on FDA

JANUARY 9, 2022

Once again it was a quiet year with respect to the FDA’s Office of Prescription Drug Programs (OPDP). In the latest published guidance agenda from the Center for Drug Evaluation and Research, the advertising and promotion category had no slated guidance efforts listed. Why This is a Fail.

FDA 64

FDA Pharma Companies Pharmaceutical Companies Treatment 64

The Pharma Data

SEPTEMBER 14, 2020

In addition, with the pressure to reduce drug waste and react quickly to study changes, implementing inadequate risk management policies can also impact clinical supply chain performance leading to budget increases and delayed timelines. Accelerating your clinical trial supply through digitalization.

Clinical Supply 52

Clinical Supply Clinical Trials Pharma Companies Trials 52

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … Deep Learning Deep learning, a subset of ML, employs neural networks with multiple layers to model complex patterns in data.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

Drug Target Review

JULY 11, 2024

To date, there are less than 30 known surface proteins that form the basis of all approved cancer-targeted therapies of all modalities, including antibody-drug conjugates (ADCs), T-cell engagers, CAR T-cells and radiopharmaceuticals. These could be targets for antibody-drug conjugates (ADCs), bi-specific antibodies, or other therapies.

Therapies 56

Therapies RNA Pharma Companies Disease 56

The Pharma Data

JANUARY 17, 2021

Connecticut-based Biohaven Pharmaceuticals was looking pretty hopeful with its third-generation prodrug to modulate glutamate, the most abundant excitatory neurotransmitter in the human body. Nonetheless, the company plans to advance the drug to a full Phase III program with a larger sample size and a higher-dose arm. .

Pharma Companies 52

Pharma Companies Disease Treatment Trials 52

Predictive Oncology

FEBRUARY 7, 2023

NEW YORK – Predictive Oncology wants to ink more partnerships with biopharmaceutical companies and demonstrate the ability of its commercially available PEDAL platform to provide early insights that sponsors can use to prioritize drugs for development and identify biomarker-informed indications.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

The Pharma Data

JANUARY 4, 2021

Rothenberg did not provide any information as to what his next role may be – whether he will take over the helm of a pharma company or assume a role on one or more boards of directors. Rothenberg took over as Pfizer CMO in January 2019, but spent more than 12 years in total working for the pharmaceutical giant.

Pharma Companies 52

Pharma Companies Clinical Development Clinical Research International 52

H1 Blog

NOVEMBER 15, 2023

Since KOLs play such a critical role, engaging with the right KOLs is a key strategy for pharmaceutical companies to stay ahead of the game. Compliance ensures that interactions between pharmaceutical companies and KOLs are transparent, fair, and free from any undue influence.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

DrugBaron

FEBRUARY 7, 2022

Finding small molecule drugs is much harder than finding a needle in a haystack – discovering the right arrangement of atoms to bind precisely to a protein target to elicit a particular response is a problem of vast dimensionality. We already talked about choosing carefully a more limited set of compounds to make.

Small Molecule 100

Small Molecule Synthetic Chemistry Pharma Companies Pharmacokinetics 100

Drug Target Review

OCTOBER 1, 2024

Following clinical practice, I transitioned to the world of pharmaceutical companies which also had its challenges as I had to learn everything from scratch and use my experience and knowledge differently. Being a doctor means giving courage and hope day in, day out to those experiencing illness.

Doctors 97

Doctors Therapies Science Pharma Companies 97

Codon

FEBRUARY 13, 2024

doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.

Therapies 124

Therapies Virus DNA Clinical Trials 124

The Pharma Data

DECEMBER 23, 2020

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. It is approved in Argentina as the world’s first therapy for severe Chronic Fatigue Syndrome and is the only late-stage drug in the U.S. Ampligen is AIM’s TLR3 agonist immune-system modulator. development pipeline for ME/CFS.

Clinical Trials 52

Clinical Trials Trials Virus Therapies 52

LifeSciVC

NOVEMBER 28, 2023

We had a significantly limited set of Phase 1B data in psoriasis patients for TYK2 at the time, and we were now free to speak to pharma companies interested in our TYK2 program. Further, there was serious doubt from many pundits that the selective allosteric TYK2’s, led by BMS’ deucravacitinib, would be a new class of drugs.

Marketing 85

Marketing FDA Pharma Companies Government 85

The Pharma Data

JANUARY 31, 2021

During his tenure, Evotec established itself as a leading drug discovery and development company with a particular focus on precision medicine through early adoption of paradigm-shifting technologies such as iPSC-based drug discovery, industrialised multi-omics, and artificial intelligence-driven data analytics throughout the drug discovery process.

Science 52

Science Government Medical Schools International 52

The Pharma Data

DECEMBER 17, 2020

Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Hartfield previously served as CEO of Vitae Pharmaceuticals prior to its acquisition by Allergan. AB2 Bio – Swiss pharma company AB2 Bio Ltd.

Small Molecule 52

Small Molecule Clinical Development Engineering Pharmaceuticals 52

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). A 2022 survey by McKinsey found that emerging biotech companies are less satisfied with their CROs than large pharma companies and reported the feeling of being underserved.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

The Anticancer Fund

JUNE 7, 2022

10 June 2022 Language EN Drug repurposing is a strategy for identifying new uses for approved drugs, outside the scope of the original indication. Below, we have listed recent findings about the repurposing of generic drugs in oncology. It is one of the focus areas of the Anticancer Fund.

Drugs 40

Drugs Clinical Trials Trials Treatment 40

Advarra

JULY 19, 2022

If the sponsor wants their drug approved, they need to complete all clinical studies and submit an application. Q: Please discuss the transfer of investigational new drug (IND) sponsorship from one sponsor to another and that process. The sponsor is the pharmaceutical company conducting the trial.

Packaging 52

Packaging FDA Trials Regulations 52

Vial

FEBRUARY 19, 2024

Explore the groundbreaking VersAptx bioconjugation platform, designed to elevate cancer therapies and uncover the delicate balance between clinical excellence and commercial viability in the dynamic landscape of pharmaceuticals. We can link small molecule drugs to a payload that would enter in the cell and kill it.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. Changes in the blood concentration profile of a drug.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

OCTOBER 14, 2020

AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. Food and Drug Administration granted Breakthrough Therapy designation to France-based Inventiva’s experimental NASH treatment lanifibranor. Inventiva – The U.S.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Therapies 52

H1 Blog

DECEMBER 11, 2024

Drug Pricing, Global Diversity Strategies, & Emerging AI Applications Each year, we compile our predictions to provide life sciences, pharmaceutical, and healthcare organizations with a comprehensive look at emerging industry trends and dynamics to help them prepare for the year ahead.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52